ADVFN - Advanced Financial Network.
HOME» NYSE » N » NVS Stock Price » NVS Stock News

Novartis Share News

 Novartis Ag Basel Stock Price
NVS Stock Price
 Novartis Ag Basel Stock Chart
NVS Stock Chart
 Novartis Ag Basel Stock News
NVS Stock News
 Novartis Ag Basel Company Information
NVS Company Information
 Novartis Ag Basel Stock Trades
NVS Stock Trades

WSJ BLOG/Health: A.M. Vitals: Texas Board to Vote on Stem-Cell Rules

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.) By Mark Long Here's what's making health news this morning: Texas Eyes Change in Stem-Cell Rules (WSJ): The state's medical board will vote today on rules that would make it easier for physicians to offer treatments using adult stem cells. Bayer Said to Pay $110 Million in Yaz Birth-Control Cases (Bloomberg News): People familiar with the agreements told Bloomberg that the German drug maker will settle about 500 lawsuits claiming the pills caused blood clots. States Seek Curb on Patient Bills for Costly Drugs (New York Times): Lawmakers in at least 20 states have introduced bills to limit the amount patients with diseases that are expensive to treat have to pay out of pocket. Medicare to Settle Hospital Reimbursement Dispute (Los Angeles Times): The Centers for Medicare and Medical Services agreed to settle the dispute with about 2,200 hospitals over an error in reimbursement rates. Sexual Side Effects Added to Merck Drug Labels (Reuters): U.S. health regulators said the labels for a baldness treatment, Propecia, and one for enlarged prostate, Proscar, will note side effects that lasted after use of the drugs ended. Hospitals Drop Plan for Merger (WSJ): St. Anthony Medical Center and Rockford Memorial Hospital in Rockford, Ill., bowed to pressure from the FTC, which said a deal would make a local monopoly. Novartis: MS Pill Gilenya Patient Develops Rare Brain Disease (Dow Jones Newswires): The multiple-sclerosis patient, diagnosed with often-fatal progressive multifocal leukoencephalopathy, had also been previously treated with another MS drug, Novartis said. -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com.

Stock News for Novartis (NVS)
DateTimeHeadline
05/17/201513:02:02Could This Be Healthcare's $158 Billion Black Swan Event?
05/17/201509:05:022 Stocks With Jaw-Dropping Growth Potential
05/12/201510:26:025 Largest Markets for Pharmaceuticals
05/11/201511:40:11Court Blocks Novartis Copy of Amgen Cancer-Care Drug
05/08/201515:04:02GlaxoSmithKline PLC Earnings: Pay No Attention to the Results...
05/08/201511:12:03The Best Fidelity Mutual Funds
05/07/201513:40:20Court Blocks Novartis Copy of Amgen Cancer-Care Drug
05/07/201513:34:24Court Blocks Novartis Copy of Amgen Cancer-Care Drug
05/06/201518:01:31ADR Shares End Mixed; Anheuser-Busch InBev Rises
05/06/201508:50:06GSK Cuts Return to Holders From Novartis Asset Swap
05/06/201507:58:20Genmab 1Q Sales of Arzerra Leukaemia Drug at GBP11.1 Million
05/04/201519:22:23Generic Drugs Grab Growing Market Share in Mexico--Update
05/04/201519:22:11Generic Drugs Grab Market Share in Mexico
05/04/201511:57:01Why Shares in Array BioPharma, Inc. Are Soaring Higher
05/02/201510:41:02The Best Way to Invest Money in Silicon Valley
05/01/201514:49:19Waiting for Exelixis, Inc.'s Meteor to Land
04/30/201513:47:19Teva Pharmaceutical Industries Ltd Posts Solid Quarter, Stays...
04/25/201507:06:02Are Biosimilars the Next Big Thing in Biotech?
04/23/201518:21:48ADR Shares End Higher; Ericsson Drops, Logitech Rises
04/23/201512:49:55Eli Lilly Results Top Expectations

Novartis and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad